Can we identify metabolically healthy but obese individuals (MHO)?

被引:221
作者
Karelis, A
Brochu, M
Rabasa-Lhoret, R
机构
[1] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1A8, Canada
[2] Univ Montreal, Dept Kinesiol, Montreal, PQ H3T 1A8, Canada
基金
加拿大健康研究院; 加拿大创新基金会;
关键词
obesity; metabolic syndrome; insulin resistance; lipid profile;
D O I
10.1016/S1262-3636(07)70156-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: A unique subset of obese individuals termed, Metabolically Healthy but Obese (MHO), has been described in the literature. However, there is no agreed upon method to identify MHO individuals for research protocols or in clinical practice. Therefore, we examined a large cohort of obese older women to attempt to develop a first set of clinical markers that may identify MHO individuals. Methods: We studied 154 obese postmenopausal women (age: 57.0 +/- 5.3 years and BMI: 34.3 +/- 5.5 kg/m(2)). Selection criteria for MHO individuals were partially based on the National Cholesterol Education Program's Adult Treatment Panel III report (ATP III) for lipid profiles (triglycerides: less than or equal to 1.7 mmol/l, total cholesterol: less than or equal to 5.2 mmol/l, HDL-cholesterol: 1.3 mmol/l and LDL-cholesterol: less than or equal to 2.6 mmol/l) and from the study of Brochu et al. (2001) for insulin sensitivity (HOMA less than or equal to 1.95). When 4 out of 5 criteria are met, we suggest that a diagnosis of the MHO individual could be made. Results: Based on the proposed criteria, 19 out of 154 (12.3%) postmenopausal women subjects were identified as MHO. By design, MHO individuals showed a favourable lipid profile and higher insulin sensitivity values. Conclusion: We suggest a potential new set of clinical markers to identify MHO individuals. Identifying MHO individuals could have important implications for therapeutic medical decision making, subject characterization in research protocols and in medical education.
引用
收藏
页码:569 / 572
页数:4
相关论文
共 11 条
[1]   What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? [J].
Brochu, M ;
Tchernof, A ;
Dionne, IJ ;
Sites, CK ;
Eltabbakh, GH ;
Sims, EAH ;
Poehlman, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1020-1025
[2]   Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus [J].
Brunzell, JD ;
Ayyobi, AF .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 :24-28
[3]  
Chevenne D, 1999, DIABETES METAB, V25, P459
[4]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[5]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[6]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
CIRCULATION, 2004, 109 (03) :433-438
[7]   Metabolic and body composition factors in subgroups of obesity: What do we know? [J].
Karelis, AD ;
St-Pierre, DH ;
Conus, F ;
Rabasa-Lhoret, R ;
Poehlman, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2569-2575
[8]  
KARELIS AD, 2004, CLIN MARKERS IDENTIF
[9]   Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women - A report from the Women's Ischemia Syndrome Evaluation (WISE) study [J].
Kip, KE ;
Marroquin, OC ;
Kelley, DE ;
Johnson, BD ;
Kelsey, SF ;
Shaw, LJ ;
Rogers, WJ ;
Reis, SE .
CIRCULATION, 2004, 109 (06) :706-713
[10]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419